Penumbra EBIT Margin 2014-2025 | PEN

Penumbra ebit margin for the quarter ending June 30, 2025 was 12.42%.

  • Penumbra average ebit margin for 2024 was 1.53%, a 64.67% increase from 2023.
  • Penumbra average ebit margin for 2023 was 4.33%, a 250.35% decline from 2022.
  • Penumbra average ebit margin for 2022 was -2.88%, a 829.03% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Penumbra EBIT Margin 2014-2025 | PEN

  • Penumbra average ebit margin for 2024 was 1.53%, a 64.67% increase from 2023.
  • Penumbra average ebit margin for 2023 was 4.33%, a 250.35% decline from 2022.
  • Penumbra average ebit margin for 2022 was -2.88%, a 829.03% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$171.7B
Intuitive Surgical (ISRG)$168.4B
IDEXX Laboratories (IDXX)$52B
Edwards Lifesciences (EW)$45.8B
Alcon (ALC)$42.1B
IQVIA Holdings (IQV)$30.4B
DexCom (DXCM)$30B
Mettler-Toledo (MTD)$25.5B
STERIS (STE)$23.2B
Waters (WAT)$16.5B
SONOVA HOLDING (SONVY)$16.4B
Hologic (HOLX)$15.1B
Sysmex ADR (SSMXY)$8.6B
Masimo (MASI)$7.9B
Globus Medical (GMED)$7.3B
Teleflex (TFX)$5.1B
Glaukos (GKOS)$5B
TransMedics (TMDX)$4B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.6B
Alphatec Holdings (ATEC)$2.2B
PROCEPT BioRobotics (PRCT)$2.2B
Veracyte (VCYT)$2.2B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Artivion (AORT)$1.4B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$990M
Integra LifeSciences Holdings (IART)$984M
OPKO Health (OPK)$976M